Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

2.4%

2 terminated/withdrawn out of 85 trials

Success Rate

94.6%

+8.1% vs industry average

Late-Stage Pipeline

18%

15 trials in Phase 3/4

Results Transparency

14%

5 of 35 completed trials have results

Key Signals

14 recruiting5 with results

Enrollment Performance

Analytics

N/A
23(46.9%)
Phase 2
11(22.4%)
Phase 3
9(18.4%)
Phase 4
6(12.2%)
49Total
N/A(23)
Phase 2(11)
Phase 3(9)
Phase 4(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (85)

Showing 20 of 85 trials
NCT07548281Not ApplicableNot Yet Recruiting

Intravascular Ultrasound- and Angiography-Derived Fractional Flow Reserve-Guided Drug-Coated Balloon for Large Coronary Artery De Novo Lesions

Role: collaborator

NCT07329699Not ApplicableRecruiting

Artificial Intelligence-Driven Medipixel Fractional Flow Reserve Versus Invasive Fractional Flow Reserve-Guided PCI Trial (AIM-FFR Trial)

Role: collaborator

NCT07497867Recruiting

Long-term Prospective Study of Korean CADASIL Patients

Role: collaborator

NCT07057648Recruiting

Shape-Sensing Robotic-Assisted Bronchoscopy for Diagnosis of Peripheral Pulmonary Nodules in Korea

Role: lead

NCT07405931Not ApplicableRecruiting

Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients

Role: lead

NCT07398001Not ApplicableNot Yet Recruiting

Discontinuation of Antiplatelet Therapy After Drug-Coated Balloon Treatment

Role: lead

NCT07373145Recruiting

Prospective CT Assessment After DCB

Role: collaborator

NCT03030495Active Not Recruiting

Registry of Comprehensive Imaging and Physiological Evaluation of Deferred Lesions Based on FFR

Role: collaborator

NCT06218485Not ApplicableRecruiting

FFR Versus IVUS with Angiography-Derived FFR for Clinical Outcomes in Patients with Coronary Artery Disease

Role: collaborator

NCT02673424Not ApplicableUnknown

Fractional FLow Reserve And IVUS for Clinical OUtcomes in Patients With InteRmediate Stenosis

Role: collaborator

NCT02619994Phase 2Completed

Treatment Shortening of MDR-TB Using Existing and New Drugs

Role: collaborator

NCT03753074Phase 4Active Not Recruiting

Effectiveness of TAF in Reducing Clinical Events in CHB Patients Beyond Treatment Indications by Current Guidelines

Role: collaborator

NCT05846893Not ApplicableRecruiting

Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease

Role: collaborator

NCT06138769Phase 2Active Not Recruiting

Lenvatinib After Progression on Atezolizumab-bevacizumab in Hepatocellular Carcinoma

Role: collaborator

NCT05389956Recruiting

Identification of Risk Factors for Cardiovascular Disease and Cancer in Korean Population: A Prospective Cohort Study

Role: lead

NCT05381194Phase 4Recruiting

BPaL(M) Regimen for the Treatment of MDR/RR-TB

Role: collaborator

NCT06305572Completed

Diagnostic Accuracy of Quantitative Flow Ratio

Role: collaborator

NCT01917552Phase 3Recruiting

Adjuvant Capecitabine Versus Observation Alone in Curatively Resected Stage IB Gastric Cancer((KCSG ST14-05): CATALYSIS

Role: collaborator

NCT04397211Not ApplicableActive Not Recruiting

Angiography-Derived FFR And IVUS for Clinical Outcomes in Patients With Coronary Artery Disease

Role: collaborator

NCT02936232Recruiting

Severe Sepsis and Septic Shock Registry

Role: collaborator